Monday, October 12, 2026

Back to today

From X

“Is Ralph Lauren Still Relevant?”

Ralph Lauren’s 2017 CEO change put Patrice Louvet in charge of reversing nine quarters of same-store sales declines and restoring the…

SLS · short

Sellas Life Sciences Group I

SELLAS Life Sciences Group faces a short case arguing that even a strong clinical outcome does not support its current valuation.

Paxman (PAX.ST)

Paxman sells chemotherapy scalp-cooling systems, expanding US reimbursement and utilization after acquiring its largest competitor in 2025.

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 108

X accounts we follow

Every account on this site, hand-picked.

89 accounts

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.